Skip to main content

Table 1 Patient characteristics in patients with AKI 2/3 compared to patients with AKI ≤2

From: Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers

 

AKI KDIGO 2/3

KDIGO 0/1

p-Value

(n = 8)

(n = 32)

Age [years]

81.4 ± 4.2

80.7 ± 5.9

n.s.

Male gender [n (%)]

3 (37.5)

13 (40.6)

n.s.

Weight [kg]

76.6 ± 13.6

70.2 ± 11.2

n.s.

Height [cm]

167.3 ± 6.6

164.7 ± 8.5

n.s.

Preoperative creatinine [mg/dl]

1.18 ± 0.26

1.12 ± 0.24

n.s.

Preoperative eGFR [ml/min/1.73 m2]

65.6 ± 15.9

65.9 ± 18.1

n.s.

Transapical approach [n (%)]

6 (75.0)

28 (87.5)

n.s.

SAPS

33.8 ± 9.7

27.0 ± 6.7

0.034

TISS

23.0 ± 4.5

22.6 ± 4.5

n.s.

LVEF [%]

49.3 ± 16.9

49.3 ± 10.9

n.s.

AVA [cm2]

0.83 ± 0.32

0.69 ± 0.22

n.s.

MPG [mmHg]

36.8 ± 23.5

42.9 ± 17.2

n.s.

Comorbidities [n (%)]

  

n.s.

 Hypertension

7 (87.5)

24 (75.0)

n.s.

 PHT

1 (12.5)

5 (15.6)

 

 Smoking

2 (25.0)

8 (25.0)

n.s.

 Diabetes

3 (37.5)

10 (31.3)

n.s.

 COPD

4 (50.0)

6 (18.8)

n.s.

 Atrial fibrillation

7 (87.5)

13 (40.6)

0.031

 Peripheral artery disease

1 (12.5)

11 (34.4)

n.s.

 Recent myocardial infarction

2 (25.0)

2 (6.3)

n.s.

 CAD

5 (62.5)

19 (59.4)

n.s.

Duration of surgery [h]

84.09 ± 0.03

84.06 ± 0.02

n.s.

Contrast agent [ml]

102.1 ± 35.8

131.0 ± 44.7

n.s.

Fluid balance on the day of surgery [ml]

2950. 0 ± 1053.8

2239.3 ± 954.6

n.s.

Cumulative catecholamine dosage on the day of surgery [μg/kgBW/min]

0.12 ± 0.09

0.06 ± 0.08

n.s

LCOS [n (%)]

1 (12.5)

0 (0)

n.s.

Sepsis [n (%)]

2 (25.0)

0 (0)

0.03

Septic shock [n (%)]

1 (12.5)

0 (0)

n.s.

LOS ICU/IMC [d]

8.3 ± 4.9

4.9 ± 3.8

n.s.

Outcomes According to VARC-2 [n (%)]

 30-d-mortality all cause

1 (12.5)

1 (3.1)

n.s.

 30-d-mortality cardiovascular

1 (12.5)

0 (0)

n.s.

 Stroke/TIA 30 d

0 (0)

1 (3.1)

n.s.

 Bleeding

  Life-threatening/disabling

1 (12.5)

0 (0)

n.s.

  Major

0 (0)

0 (0)

n.s.

  Minor

0 (0)

0 (0)

n.s.

 Unplanned use of CPB

0 (0)

0 (0)

n.s.

 Conversion to open surgery

0 (0)

0 (0)

n.s.

 Pacemaker implantation

1 (12.5)

0 (0)

n.s.

 Myocardial infarction

0 (0)

0 (0)

n.s.

 Procedure success

8 (100)

32 (100)

n.s.

 Access site complications

  minor

0 (0)

0 (0)

n.s.

  major

0 (0)

0 (0)

n.s.

  1. COPD chronic obstructive pulmonary disease, SAPS Simplified Acute Physiology Score, TISS Therapeutic Intervention Scoring System, eGFR estimated glomerular filtration rate, ICU intensive care unit, IMC intermediate care unit, LVEF left ventricular ejection fraction, PHT pulmonary hypertension, CAD coronary artery disease, LCOS Low cardiac output syndrome, LOS length of stay, VARC Valve Academic Research Consortium